![](/img/cover-not-exists.png)
Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era
Ferreri, Andrés J. M., Bruno-Ventre, Marta, Donadoni, Giovanni, Ponzoni, Maurilio, Citterio, Giovanni, Foppoli, Marco, Vignati, Alessandro, Scarfò, Lydia, Sassone, Marianna, Govi, Silvia, Caligaris-CaVolume:
168
Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.13194
Date:
March, 2015
File:
PDF, 210 KB
english, 2015